^18F-FDG PET/CT在早期非小细胞肺癌立体定向放疗疗效评估中的应用价值  

^18F-FDG PET/CT in evaluation of the outcome after stereotactic body radiation therapy for early-stage non-small cell lung cancer

作　　者：董敏[1] 孙晓蓉[2] 邢力刚[1] 

机构地区：[1]山东省肿瘤医院放疗科,济南250117 [2]山东省肿瘤医院PET/CT中心,济南250117

出　　处：《中华核医学与分子影像杂志》2015年第2期157-160,共4页Chinese Journal of Nuclear Medicine and Molecular Imaging

摘　　要：立体定向放疗（SBRT）越来越广泛地应用于早期NSCLC的治疗,已成为无法耐受手术的早期NSCLC患者的标准治疗技术.相较于其他影像学方法,^18F-FDG PET/CT在NSCLC的诊断、分期和疗效预测中具有更高的准确性,其在SBRT疗效判断和预后预测方面的作用也日益得到重视,笔者就该领域的研究进展做一综述.Stereotactic body radiation therapy （SBRT） has been increasingly used in the treatment of early-stage NSCLC,especially for patients who cannot undergo surgery.Compared with other imaging modalities,PET/CT has higher sensitivity and specificity in diagnosis and staging of NSCLC as well as higher prediction value for prognosis.The progress of ^18F-FDG PET/CT in evaluation of the therapeutic response and prognosis after SBRT for early-stage NSCLC is summarized in this review.

关 键 词：放射疗法 癌 非小细胞肺 体层摄影术 发射型计算机 体层摄影术 X线计算机 发展趋势 

分 类 号：R734.2[医药卫生—肿瘤]